EVALUATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN QUÉBEC USING NEWLY-ESTABLISHED CANADIAN CARDIOVASCULAR SOCIETY QUALITY INDICATORS
Laurie Lambert(Institut National d'Excellence en Santé et en Services Sociaux), Peter Bogaty(Institut universitaire de cardiologie et de pneumologie de Québec), G. Martucci(Royal Victoria Hospital), G. Sas, Benoit Daneault(Université de Sherbrooke), Anita Asgar(Montreal Heart Institute), Normand Racine(Montreal Heart Institute), Benoît DeVarennes(Royal Victoria Hospital), Brian J. Potter(Johnson University), L. Azzi(Institut National d'Excellence en Santé et en Services Sociaux), Nicolas Noiseux(Centre Hospitalier de l’Université de Montréal), R. Ibrahim(Montreal Heart Institute), Yoan Lamarche(Montreal Heart Institute), M. Carrier(Montreal Heart Institute), Philippe Généreux(Morristown Medical Center)
Cited by 0
Related Papers
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research
|Journal of the American College of Cardiology|2021|1.2k
Transcatheter Aortic Valve Implantation for the Treatment of Severe Symptomatic Aortic Stenosis in Patients at Very High or Prohibitive Surgical Risk
|Journal of the American College of Cardiology|2010|973
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
|New England Journal of Medicine|2013|825
Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research
|European Heart Journal|2020|817